Responses of the embryonic epigenome to maternal diabetes

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 94, Issue 10, 2012, Pages 770-781

  Salbaum, J Michael ^a   Kappen, Claudia ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Chromatin; Diabetic embryopathy; Epigenetic; Gene expression; High fat diet; Inbred mouse; Neural; Obesity; Tube defect

Indexed keywords

HISTONE H3; HISTONE H4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; EPIGENETICS; FEMALE; GENETIC ASSOCIATION; HISTONE ACETYLATION; LIPID DIET; MALE; MATERNAL DIABETES MELLITUS; MATERNAL OBESITY; MORPHOMETRICS; MOUSE; MOUSE MUTANT; NEURAL TUBE DEFECT; NEURULATION; NONHUMAN; PRIORITY JOURNAL;

ALGORITHMS; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES, GESTATIONAL; DIET, HIGH-FAT; DIETARY FATS; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; EPIGENESIS, GENETIC; EPIGENOMICS; FEMALE; MALE; MICE; MICE, INBRED C57BL; PREGNANCY; PREGNANCY IN DIABETICS; PRENATAL EXPOSURE DELAYED EFFECTS; STREPTOZOCIN;

EID: 84867686668     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.23035     Document Type: Article

References (52)

1. Aagaard-Tillery KM, Grove K, Bishop J, et al. 2008. Developmental origins of disease and determinants of chromatin structure: maternal diet modifies the primate fetal epigenome. J Mol Endocrinol 41: 91-102.
2. Baker L, Piddington R. 1993. Diabetic embryopathy: a selective review of recent trends. J Diabetes Complications 7: 204-212.
3. Bernstein BE, Mikkelsen TS, Xie X, et al. 2006. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315-326.
4. Bien-Willner GA, Staukiewicz P, Lupski JR. 2007. Soxgcre1, a cis-acting regulatory element located 1.1 Mb upstream of SOXS, mediates its enhancement through the SHH pathway. Hum Mol Genet 16: 1143-1156.
5. Brydon P, Smith T, Proffitt M, et al. 2000. Pregnancy outcome in women with type 2 diabetes mellitus needs to be addressed. Int J Clin Pract 54: 418-419.
6. Buchanan TA, Kitzmiller JL. 1994. Metabolic interactions of diabetes and pregnancy. Annu Rev Med 45: 245-260.
7. Carver TD, Anderson SM, Aldoretta PA, Esler AL, Hay WWJr. 1995. Glucose suppression of insulin secretion in chronically hyperglycemic fetal sheep. Pediatr Res 38: 754-762.
8. Casson IF, Clarke CA, Howard CV, et al. 1997. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 315: 275-278.
9. Cedergren MI, Kallen BA. 2003. Maternal obesity and infant heart defects. Obes Res 11: 1065-1071.
10. Chung CS, Myrianthopoulos NC. 1975. Factors affecting risks of congenital malformations. II. Effect of maternal diabetes on congential malformations. Birth Defects Orig Artic Ser 11: 23-37.
11. Cleves MA, Hobbs CA. 2004. Collaborative strategies for unraveling the complexity of birth defects. J Matern Fetal Neonatal Med 15: 35-38.
12. Corrigan N, Brazil DP, McAuliffe F, et al. 2009. Fetal cardiac effects of maternal hyperglycemia during pregnancy. Birth Defects Res A Clin Mol Teratol 85: 523-530.
13. Creyghton MP, Cheng AW, Welstead GG, et al. 2010. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci USA 107: 21931-21936.
14. Davison JM, Mellott TJ, Kovacheva VP, et al. 2009. Gestational choline supply regulates methylation of histone H3, expression of histone methyltransferases G9a (Kmt1c) and Suv39h1 (Kmt1a), and DNA methylation of their genes in rat fetal liver and brain. J Biol Chem 284: 1982-1989.
15. Eriksson UJ, Borg LA, Forsberg H, Styrud J. 1991. Diabetic embryopathy. Studies with animal and in vitro models. Diabetes 40( Suppl 2): 94-98.
16. Feldman N, Gerson A, Fang J, et al. 2006. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat Cell Biol 8: 188-194.
17. Freinkel N. 1988. Diabetic embryopathy and fuel-mediated organ teratogenesis: lessons from animal models. Horm Metabol Res 20: 463-475.
18. Goldman AS, Baker L, Piddington R, et al. 1985. Hyperglycemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid. Proc Natl Acad Sci USA 82: 8227-8231.
19. Greene MF. 1999. Spontaneous abortions and major malformations in women with diabetes mellitus. Semin Reprod Endocrinol 17: 127-136.
20. Harris MJ, Juriloff DM. 2010. An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure. Birth Defects Res A Clin Mol Teratol 88: 653-669.
21. Honma K, Mochizuki K, Goda T, et al. 2009. Inductions of histone H3 acetylation at lysine 9 on SGLT1 gene and its expression by feeding mice a high carbohydrate/fat ratio diet. Nutrition 25: 40-44.
22. Huang da W, Sherman BT, Lempicki RA. 2009a. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13.
23. Huang da W, Sherman BT, Lempicki RA. 2009b. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
24. Imoberdorf RM, Topalidou I, Strubin M, et al. 2006. A role for gcn5-mediated global histone acetylation in transcriptional regulation. Mol Cell Biol 26: 1610-1616.
25. Jiang B, Kumar SD, Loh WT, et al. 2008. Global gene expression analysis of cranial neural tubes in embryos of diabetic mice. J Neurosci Res 86: 3481-3493.
26. Kousseff BG. 1999. Gestational diabetes mellitus (class A): a human teratogen? Am J Med Genet 83: 402-408.
27. Kucera J. 1971. Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 7: 73-82.
28. Lin W, Zhang Z, Srajer G, et al. 2008. Proper expression of the Gcn5 histone acetyltransferase is required for neural tube closure in mouse embryos. Dev Dyn 237: 928-940.
29. Loffredo CA, Wilson PD, Ferencz C, et al. 2001. Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants. Teratology 64: 98-106.
30. Mikkelsen TS, Ku M, Jaffe DB, et al. 2007. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448: 553-560.
31. Mills JL. 1982. Malformations in infants of diabetic mothers. Teratology 25: 385-394.
32. Pavlinkova G, Salbaum JM, Kappen C, 2008. Wnt signaling in caudal dysgenesis and diabetic embryopathy. Birth Defects Res A Clin Mol Teratol 82: 710-719.
33. Pavlinkova G, Salbaum JM, Kappen C, 2009. Maternal diabetes alters transcriptional programs in the developing embryo. BMC Genomics 10: 274.
34. Reece EA. 1999. Maternal fuels, diabetic embryopathy: pathomechanisms and prevention. Semin Reprod Endocrinol 17: 183-194.
35. Reece EA, Eriksson UJ. 1996. The pathogenesis of diabetes-associated congenital malformations. Obstet Gynecol Clin North Am 23: 29-45.
36. Rosenfeld JA, Wang Z, Schones DE, et al. 2009. Determination of enriched histone modifications in non-genic portions of the human genome. BMC Genomics 10: 143.
37. Sakamaki H, Akazawa S, Ishibashi M, et al. 1999. Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes 48: 1138-1144.
38. Salbaum JM, Kappen C. 2010. Neural tube defect genes and maternal diabetes during pregnancy. Birth Defects Res A Clin Mol Teratol 88: 601-611.
39. Salbaum JM, Kappen C. 2011. Diabetic embryopathy: a role for the epigenome? Birth Defects Res A Clin Mol Teratol 91: 770-780.
40. Stephens E, Thureen PJ, Goalstone ML, et al. 2001. Fetal hyperinsulinemia increases farnesylation of p21 Ras in fetal tissues. Am J Physiol Endocrinol Metab 281: E217-E223.
41. Suka N, Suka Y, Carmen AA, et al. 2001. Highly specific antibodies determine histone acetylation site usage in yeast heterochromatin and euchromatin. Mol Cell 8: 473-479.
42. Szerlong HJ, Prenni JE, Nyborg JK, et al. 2010. Activator-dependent p300 acetylation of chromatin in vitro: enhancement of transcription by disruption of repressive nucleosome-nucleosome interactions. J Biol Chem 285: 31954-31964.
43. Visel A, Blow MJ, Li Z, et al. 2009. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457: 854-858.
44. Wagschal A, Sutherland HG, Woodfine K, et al. 2008. G9a histone methyltransferase contributes to imprinting in the mouse placenta. Mol Cell Biol 28: 1104-1113.
45. Waller DK, Mills JL, Simpson JL, et al. 1994. Are obese women at higher risk for producing malformed offspring? Am J Obstet Gynecol 170: 541-548.
46. Waterland RA, Jirtle RL. 2003. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 23: 5293-5300.
47. Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA. 2003. Maternal obesity and risk for birth defects. Pediatrics 111: 1152-1158.
48. Wellen KE, Hatzivassiliou G, Sachdeva UM, et al. 2009. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324: 1076-1080.
49. Wentzel P, Wentzel CR, Gareskog MB, et al. 2001. Induction of embryonic dysmorphogenesis by high glucose concentration, disturbed inositol metabolism, and inhibited protein kinase C activity. Teratology 63: 193-201.
50. Yao TP, Oh SP, Fuchs M, et al. 1998. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93: 361-372.
51. Zaken V, Kohen R, Ornoy A, et al. 2001. Vitamins C and E improve rat embryonic antioxidant defense mechanisms in diabetic culture medium. Teratology 64: 33-44.
52. Zang C, Schones DE, Zeng C, et al. 2009. A clustering approach for identification of enriched domains from histone modification ChIP-Seq data. Bioinformatics 25: 1952-1958.